ClinicalTrials.gg
CompletedNCT03961477[PTREC]Updated May 23, 2019

Effect of Interferential l Therapy on Low Back Pain

An interventional study of Interferential therapy in Low Back Pain, sponsored by Ahlia University. Completed at 2 sites in Egypt. Open to participants aged 25 Years to 60 Years. Per ClinicalTrials.gov, last updated 2019-05-23.

Sponsored by Ahlia University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 1 year 5 months after the study started (first participant enrolled Dec 2017, registered May 2019).
Phase
Not applicable
Study type
Interventional
Enrollment
61
Allocation
Randomized
Ages
25 Years to 60 Years
Sex
All
01

Study summary

Background: Chronic non-specific low back pain is defined as unknown mechanical musculoskeletal pain lasting more than 3 months. Electrotherapy is a non-pharmacologic, non-invasive and simple method back pain treatment that is mainly applied using interferential (IF) therapy. The current study was designed to investigate the effect of IF on pain, range of motion, and quality of life in patients with chronic non-specific low back pain. Materials and methods: 61 patients suffered from chronic non-specific low back pain (CNLBP) were randomly assigned to IF group (n=30) and placebo IF (n=31). The entire patient received suggested exercise 3 times per week for 4 weeks. The outcome measures were visual analogue scale (VAS), lumbar range of motion (ROM) in terms of flexion\& extension and the Short Form-36 (SF-36) health questionnaire to evaluate the quality of life (QOL).

Read the detailed description

Participants The study was conducted in outpatient clinics in Cairo University Hospitals. 60 patients (29 males and 31 females) were invited to participate in the current study. Subjects were included in the study if they had LBP of at least three months duration and aged between 25 and 60 years. Patients with spinal pathology (tumor, nerve root, fracture, and compromise), cardiopulmonary conditions, pregnancy, and received physiotherapy in the last eight weeks or any contraindications to the use of electrotherapy were excluded.

02

Conditions studied

  • Low Back Pain

Browse trials for

Keywords

  • Low Back Pain,
  • Interferential Therapy
  • Quality of Life
03

In context

Low Back Pain

2,875 studies on the registry are indexed under Low Back Pain; 484 are open to participants now.

This study's enrollment of 61 is close to the median of 60 across 2,315 interventional studies indexed under Low Back Pain.

Browse Low Back Pain studies →

Lead sponsor

Ahlia University is the lead sponsor of 8 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
25 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

*Subjects were included in the study if they had LBP of at least three months duration * Age between 25 and 60 years.

Exclusion criteria

Exclusion Criteria:

  • Patients with spinal pathology (tumor, nerve root, fracture, and compromise),
  • Cardiopulmonary conditions
  • Pregnancy,
  • Received physiotherapy in the last eight weeks
  • Any contraindications to the use of electrotherapy were excluded.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
61 participants (actual)

Study arms

  • Active comparator
    IF group

    Interferential therpapy

    Other: Interferential therapy

  • No intervention
    Placebo

    No intervention

Interventions

  • OtherInterferential therapy

    Exercise therapy

    Also known as: Exercise therapy

06

What researchers measure

Primary outcomes

  1. Visual Analogue Scale (VAS)

    The severity of pain was evaluated using a visual analogue scale (VAS). The participants were requested to put a line on the scale perpendicularly that matched to their pain intensity. VAS scores represent the pain intensity as none, mild, moderate, or severe. The accompanying cutoff was used for the pain scale: 0- 4 , no pain; 5- 44, mild pain; 45- 74, moderate pain; and 75-100, severe pain

    Time frame: 6 months

07

Study locations

2 sites
  • Dr Dalia Kamel
    Giza, Egypt
  • Dr Sayed Tanatwy
    Giza, Egypt
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 23, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03961477
Lead sponsor
Ahlia University
Collaborators
Cairo University
Responsible party
Dr Sayed Tantawy (Professor, Ahlia University) — Principal investigator
First posted
May 23, 2019
Start date
Dec 5, 2017
Primary completion
Jul 11, 2018
Completion
Sep 23, 2018
Last update
May 23, 2019

Study contacts

Sayed A Tantawy, PhD
study director · Cairo University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion